Arrowstreet Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $102M | Buy |
|
|||||
|
2024
Q4 | $1.08M | Sell |
|
|||||
|
2024
Q3 | $122M | Buy |
|
|||||
|
2024
Q2 | $67.1M | Buy |
|
|||||
|
2024
Q1 | $43.1M | Buy |
|
|||||
|
2023
Q4 | $5.64M | Buy |
|
|||||
|
2023
Q3 | $3.63M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $16.3M | Sell |
|
|||||
|
2022
Q4 | $374M | Buy |
|
|||||
|
2022
Q3 | $124M | Buy |
|
|||||
|
2022
Q2 | $133M | Sell |
|
|||||
|
2022
Q1 | $175M | Buy |
|
|||||
|
2021
Q4 | $85.9M | Buy |
|
|||||
|
2021
Q3 | $55.4M | Buy |
|
|||||
|
2021
Q2 | $30.7M | Buy |
|
|||||
|
2021
Q1 | $17.2M | Buy |
|
|||||
|
2020
Q4 | $455K | Sell |
|
|||||
|
2020
Q3 | $148M | Sell |
|
|||||
|
2020
Q2 | $268M | Sell |
|
|||||
|
2020
Q1 | $404M | Buy |
|
|||||
|
2019
Q4 | $384M | Buy |
|
|||||
|
2019
Q3 | $281M | Buy |
|
|||||
|
2019
Q2 | $276M | Sell |
|
|||||
|
2019
Q1 | $450M | Buy |
|
|||||
|
2018
Q4 | $280M | Buy |
|
|||||
|
2018
Q3 | $268M | Buy |
|
|||||
|
2018
Q2 | $52.1M | Buy |
|
|||||
|
2018
Q1 | $22.8M | Buy |
|
|||||
|
2017
Q4 | $13.4M | Buy |
|
|||||
|
2017
Q3 | $1.98M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $98.6M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5.61M | Sell |
|
|||||
|
2016
Q2 | $10.2M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $41.9M | Sell |
|
|||||
|
2015
Q3 | $123M | Buy |
|
|||||
|
2015
Q2 | $10.9M | Buy |
|
|||||
|
2015
Q1 | $7.31M | Sell |
|
|||||
|
2014
Q4 | $137M | Sell |
|
|||||
|
2014
Q3 | $247M | Buy |
|
|||||
|
2014
Q2 | $24.1M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.73M | Sell |
|
|||||
|
2013
Q3 | $20M | Sell |
|
|||||
|
2013
Q2 | $66.9M | Buy |
|